Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): Countrywide spread of OXA-23-producing clones (CC15 and CC79)

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 4, 2014, Pages 468-472

  Chagas, Thiago Pavoni Gomes ^a   Carvalho, Karyne Rangel ^a   de Oliveira Santos, Ivson Cassiano ^a   Carvalho Assef, Ana Paula D'Alincourt ^a   Asensi, Marise Dutra ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Acinetobacter baumannii; Brazil; Carbapenem resistance; MLST; OXA 23

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE OXA-23; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLAOXA 15 LIKE GENE; BLAOXA 23 LIKE GENE; BRAZIL; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; DISK DIFFUSION; EPSILOMETER TEST; GENE CLUSTER; GENOTYPE; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; ALLELE; CROSS INFECTION; DRUG EFFECTS; GENETICS; HUMAN; MEDICAL GEOGRAPHY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ALLELES; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; CROSS INFECTION; GEOGRAPHY, MEDICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION;

EID: 84904129116     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.03.006     Document Type: Article

References (28)

1. OXA-23 collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 2009, 34:25-28.
2. OXA-51-like genes in a Korean hospital. Jpn J Infect Dis 2012, 65:162-166.
3. Clímaco E.C., Oliveira M.L., Pitondo-Silva A., Oliveira M.G., Medeiros M., Lincopan N., et al. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil. Infect Genet Evol 2013, 19C:127-133.
4. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for antimicrobial susceptibility testing: twenty-second informational supplement. Wayne, PA: CLSI; 2012.
5. Dalla-Costa L.M., Coelho J.M., Souza H.A., Castro M.E., Stier C.J., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003, 41:3403-3406.
6. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 2010, 5:e10034.
7. Di Popolo A., Giannouli M., Triassi M., Brisse S., Zarrilli R. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries using a multilocus sequencing typing scheme. Clin Microbiol Infect 2011, 17:197-201.
8. OXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother 2009, 52:4045-4047.
9. Fiorilli G., Faccone D., Lopardo H., Callejo R., Rapoport M., Prieto M., et al. Emergence of metallo-beta-lactamases in Acinetobacter spp clinical isolates from Argentina. Rev Esp Quimioter 2010, 23:100-102.
10. Gales A.C., Castanheira M., Jones R.N., Sader H.S. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012, 73:354-360.
11. Gogou V., Pournaras S., Giannouli M., Voulgari E., Piperaki E.T., Zarrilli R., et al. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 2011, 66:2767-2772.
12. Grosso F., Carvalho K.R., Quinteira S., Ramos A., Carvalho-Assef A.P., Asensi M.D., et al. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?. J Antimicrob Chemother 2011, 66:62-65.
13. Gundi V.A., Dijkshoorn L., Burignat S., Raoult D., La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 2009, 155:2333-2341.
14. Higgins P.G., Lehmann M., Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010, 35:305-314.
15. Karah N., Sundsfjord A., Towner K., Samuelsen Ø. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 2012, 15:237-247.
16. Martins N., Martins I.S., de Freitas W.V., de Matos J.A., Girão V.B., Coelho-Souza T., et al. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients. Microb Drug Resist 2013, 19:216-223.
17. KPC gene. Antimicrob Agents Chemother 2008, 52:1257-1263.
18. Nordmann P., Poirel L., Carrër A., Toleman M.A., Walsh T.R. How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
19. OXA-51-like gene in Porto Alegre, Southern Brazil. Epidemiol Infect 2013, 141:330-333.
20. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
21. Poirel L., Nordmann P. Acquired carbapenem-hydrolysing β-lactamases and their genetic support. Curr Pharm Biotechnol 2005, 3:117-127.
22. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
23. Stietz M.S., Ramírez M.S., Vilacoba E., Merkier A.K., Limansky A.S., Centrón D., et al. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 2013, 14:294-301.
24. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Piker R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
25. Vaneechoutte M., Dijkshoorn L., Tjernberg I., Elaichouni A., de Vos P., Claeys G., et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995, 33:11-15.
26. Villalon P., Valdezate S., Medina-Pascual M.J., Rubio V., Vindel A., Saez-Nieto J.A. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J Clin Microbiol 2011, 49:875-882.
27. Villegas M.V., Kattan J.N., Correa A., Lolans K., Guzman A.M., Woodford N., et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob Agents Chemother 2007, 51:2001-2004.
28. Zarrilli R., Pournaras S., Giannouli M., Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013, 41:11-19.